Fenbendazole 222mg Capsules For Humans
Fenbendazole is a broad-spectrum medication that can kill worms in both freshwater and saltwater fish. It’s also effective against nematodes and certain tapeworms. It has limited absorption in the digestive tract and requires food to enhance its effectiveness. Extended high-dose use can cause asymptomatic changes in liver enzymes, but these are usually reversible.
Medicinal Purpose
Fenbendazole is a medication that works by blocking the synthesis of microtubules. This kills parasites and other diseases by halting the polymerization of tubulin dimers that are found in their cells. It is mostly used to treat animal parasite illnesses. However, it is gaining interest due to its potential role in cancer treatment and prevention in humans.
This antiparasitic is also effective against nematodes, tapeworms, and protozoa. It is a broad-spectrum drug that eradicates parasitic infections quickly. It has low toxicity and is safe for aquatic organisms. It is also a good choice for fish as it doesn’t accumulate in the fish’s tissue and does not cause harm to other animals that consume the fish.
The benzimidazole family of drugs has been shown to have significant anticancer activity in lab experiments. In the experiments, mice were injected with tumors and then treated with either a placebo or fenbendazole. The fenbendazole showed significantly less tumor growth than placebos. The effect was even greater when fenbendazole was combined with vitamins.
Dosage
Fenbendazole is a broad-spectrum benzimidazole used to treat nematodal infections and gastrointestinal parasites. It has also been studied as a potential cancer therapy drug, showing promise in shrinking tumors and complementing conventional treatment methods. Fenbendazole can be taken orally and is easily absorbed by the body, though it may cause symptoms of detoxification during the first few weeks of treatment. These can include stomach pain and diarrhea.
When administered orally, fenbendazole is effective against hookworms, whipworms, roundworms, pinworms and certain tapeworms including Giardia and Strongyles. It has a number of anti-cancer effects, including inducing apoptosis, inhibiting glucose uptake in cancer cells and reactivating the p53 gene. Because fenbendazole is so safe and effective, it can be administered alongside other cancer treatments to improve outcomes. Those considering fenbendazole should consult with a healthcare provider or veterinarian for personalized guidance and dosage recommendations. This service and data are provided “AS IS”. See DVMetrics Terms of Use for more information.
Side Effects
Fenbendazole is a broad-spectrum anthelmintic, used to treat parasitic infections in a wide variety of animal species. It belongs to a group of drugs called benzimidazoles and has been in use for decades. It has a wide safety profile, with few side effects reported in toxicological studies.
In addition to inhibiting tumor cell growth, fenbendazole interferes with the cancer cells’ ability to process sugar and boosts production of a gene that kills cancer cells. The drug also blocks the enzymes that break down proteins in the cell.
The drug is given orally in granules or as a liquid suspension. It should be given with food to reduce gastrointestinal irritation. It may cause stomach discomfort, diarrhea (primarily with extended high-dose usage) or asymptomatic liver enzyme elevation in extended, high-dose therapy.
When administered to mice with EMT6 tumors, a fenbendazole-containing diet prevented the tumors from growing to a volume that was four times their initial size. Neither local invasion into the body wall nor lymph node metastases were observed.
Interactions
Fenbendazole is a powerful antiparasitic drug that can kill a variety of parasites. It has also shown potential as a cancer treatment. It can kill cancer cells by reactivating the p53 gene, causing apoptosis, and inhibiting glucose uptake.
The fenbendazole cancer protocol has gained considerable attention and interest recently, after several cases of people using a combination of the ketogenic diet, and fenbendazole – also known as Panacur C – eliminating their cancer tumors.
The data from the first experiment are included in Table 1. Results from three additional experiments are shown in Figure 2. These studies tested whether fenbendazole, administered as three daily injections or incorporated into the diet, alters the growth of unirradiated and irradiated EMT6 tumors. Tumors were measured for volume, and time to four-fold tumor volume was recorded. Initial complete blood counts demonstrated that the fenbendazole-treated groups had a reduced white cell count with a paucity of neutrophils. These results are consistent with the observed effect of fenbendazole on the growth of EMT6 tumors in vitro.fenbendazole 222mg capsules for humans